Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128394) titled 'Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Nanjing University
Condition:
Infertility, Female
Luteinizing Hormone (LH)
Intervention:
Drug: Recombinant Luteinizing Hormone (rLH)
Drug: Recombinant Follicle-Stimulating Hormone (rFSH)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 1, 2024
Target Sample Size: 590
Countries...